News & Updates
Filter by Specialty:
COVID-linked MIS-C outcomes reassuring at 6 months
Children and young adults with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection show good cardiovascular and noncardiovascular outcomes at 6 months, according to data from the long-term MUSIC study.
COVID-linked MIS-C outcomes reassuring at 6 months
31 Jan 2025
Sit less, move more, as CV risk remains even with exercise
For individuals who sit for the most part of their day, engaging in light or moderate physical activity may be insufficient to cancel out the cardiovascular (CV) risks tied to a sedentary lifestyle, a study suggests.
Sit less, move more, as CV risk remains even with exercise
27 Jan 2025
Recurrence scores from 21-gene assay help inform benefits of adjuvant anthracyclines in EBC
The recurrence score derived from a 21-gene expression assay may indicate which patients with early-stage HR+ breast cancer can maintain freedom from distant recurrence for longer with the inclusion of an anthracycline in adjuvant chemotherapy, suggests a post hoc analysis of the TAILORx trial presented at SABCS 2024
